Patents by Inventor Thomas E. Cleveland

Thomas E. Cleveland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8563934
    Abstract: A system and method for fluorescence spectral imaging of target material to detect the presence of a contaminant (such as aflatoxin in corn) is provided. An ultraviolet light source is coupled with a light-excluding compartment. The fluorescence from the UV excited target passes through a filter (liquid crystal tunable, acoustic-optic tunable, a filter wheel, or other wavelength splitting device) and a lens, to a spectral imaging camera. Fluorescence spectral image data from the camera are analyzed by a computer and presented in human-readable form. Aflatoxin detection in contaminated corn kernels is based on peak fluorescence and peak fluorescence shift in the spectral range from 451 nm to 500 nm. Aflatoxin contamination level within the target material is quantified based on peak fluorescence and peak fluorescence shift and computed corn kernel pixel statistics.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: October 22, 2013
    Assignee: Mississippi State University
    Inventors: Haibo Yao, Zuzana Hruska, Russell D. Kincaid, Thomas E. Cleveland, Robert L. Brown
  • Patent number: 8563599
    Abstract: Two distinct methods are disclosed and claimed for synthesizing glyceollin I plus glyceollin II as a mixture and as their pure forms. Stereochemical isomers and various synthetic intermediates are also synthesized and claimed for their novel compositions of matter. All compounds and their mixtures are claimed for use in formulations that are useful to treat or prevent cancer, or that have utility as selective estrogen receptor modulators, such formulations including enhanced or medical foods, dietary supplements and ethical pharmaceutical agents.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: October 22, 2013
    Assignees: The United States of America, represented by the Secretary of Agriculture, Xavier University of Louisiana, University of Toledo
    Inventors: Paul W. Erhardt, Rahul Khupse, Jefferey G. Sarver, Thomas E. Cleveland, Stephen M. Boue, Thomas E. Wiese, Matthew E. Burow, John A. McLachlan
  • Publication number: 20130041022
    Abstract: The present disclosure demonstrates the molecular effects of glyceollins on human prostate cancer cell LNCaP to further elucidate its potential effects on prostate cancer prevention. The glyceollins inhibited LNCaP cell growth similar to that of the soy isoflavone genistein. The growth inhibitory effects of the glyceollins appeared to be due to an inhibition on G1/S progression and correlated with an up-regulation of cyclin-dependent kinase inhibitor A1 and B1 mRNA and protein levels. By contrast, genistein only up-regulates cyclin-dependent kinase inhibitor A1. In addition, glyceollin treatments led to down-regulated mRNA levels for androgen responsive genes. In contrast to genistein, this effect of glyceollins on androgen responsive genes appeared to be mediated through modulation of an estrogen- but not androgen-mediated pathway.
    Type: Application
    Filed: December 22, 2009
    Publication date: February 14, 2013
    Applicants: UNITED STATES DEPARTMENT OF AGRICULTURE, THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Thomas E. Cleveland, Stephen M. Boue, Matthew E. Burow, Thomas T.Y. Wang
  • Patent number: 8323706
    Abstract: The flavonoid family of phytochemicals, particularly those derived from soy, has received attention regarding their hormonal activity and their effects on human health and disease. The types and amounts of these compounds in soy and other plants are controlled by both constitutive expression and stress-induced biosynthesis. The health benefits of soy may therefore be dependent upon the amounts of the various hormonally active phytochemicals present. We have identified increased biosynthesis of the isoflavonoid phytoalexin compounds, Glyceollins I, II and III, in soy plants grown under stressed conditions (elicited soy), which exhibit marked anti-estrogenic effects on ER function.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: December 4, 2012
    Assignees: The United States of America, as represented by the Secretary of Agriculture, Tulane Educational Fund
    Inventors: Thomas E. Cleveland, Stephen M. Boue, Matthew E. Burow, John A. McLachlan
  • Publication number: 20120061586
    Abstract: A system and method for fluorescence spectral imaging of target material to detect the presence of a contaminant (such as aflatoxin in corn) is provided. An ultraviolet light source is coupled a light-excluding compartment. The fluorescence from the UV excited target passes through a filter (liquid crystal tunable, acoustic-optic tunable, a filter wheel, or other wavelength splitting device) and a lens, to a spectral imaging camera. Fluorescence spectral image data from the camera is analyzed by a computer and presented in human-readable form. Aflatoxin detection in contaminated corn kernels is based on peak fluorescence and peak fluorescence shift in the spectral range from 451 nm to 500 nm. Aflatoxin contamination level within the target material is quantified based on peak fluorescence and peak fluorescence shift and computed corn kernel pixel statistics.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 15, 2012
    Inventors: Haibo Yao, Zuzana Hruska, Russell D. Kincaid, Thomas E. Cleveland, Robert L. Brown
  • Publication number: 20110144195
    Abstract: Two distinct methods are disclosed and claimed for synthesizing glyceollin I plus glyceollin II as a mixture and as their pure forms. Stereochemical isomers and various synthetic intermediates are also synthesized and claimed for their novel compositions of matter. All compounds and their mixtures are claimed for use in formulations that are useful to treat or prevent cancer, or that have utility as selective estrogen receptor modulators, such formulations including enhanced or medical foods, dietary supplements and ethical pharmaceutical agents.
    Type: Application
    Filed: March 3, 2009
    Publication date: June 16, 2011
    Inventors: Paul W. Erhardt, Rahul Khupse, Jeffrerey G. Sarver, Thomas E. Cleveland, Stephen M. Boue, Thomas E. Wiese, Matthew E. Burow, John A. McClachlan
  • Publication number: 20080200537
    Abstract: The flavonoid family of phytochemicals, particularly those derived from soy, has received attention regarding their hormonal activity and their effects on human health and disease. The types and amounts of these compounds in soy and other plants are controlled by both constitutive expression and stress-induced biosynthesis. The health benefits of soy may therefore be dependent upon the amounts of the various hormonally active phytochemicals present. We have identified increased biosynthesis of the isoflavonoid phytoalexin compounds, Glyceollins I, II and III, in soy plants grown under stressed conditions (elicited soy), which exhibit marked anti-estrogenic effects on ER function.
    Type: Application
    Filed: April 11, 2008
    Publication date: August 21, 2008
    Inventors: Thomas E. Cleveland, Stephen M. Boue, Matthew E. Burow, John A. McLachlan
  • Publication number: 20080102487
    Abstract: In a method and apparatus for identifying and distinguishing fungal species, a hyperspectral imaging scanner is used to acquire hyperspectral image data for radiation obtained from a sample area in which at least one unknown fungal species is present. A computer compares the acquired hyperspectral image data with spectral signature data stored in a digital library, which includes spectral signature data for each one of a group of known fungal species, and identifies the fungal species, based on the result of such comparison. The spectral signature data stored in the digital library take into account, for each fungal species, spectral variations that can occur due to at least one of environmental and temporal influences. The computer comparison includes a pixel-by-pixel analysis of the degree of difference between acquired hyperspectral image data and the spectral signature data, so that a spatial distribution of identified fungal species can be determined for a sample area.
    Type: Application
    Filed: November 1, 2006
    Publication date: May 1, 2008
    Applicants: Institute for Technology Development, USDA Southern Regional Research Center
    Inventors: Haibo Yao, Zuzana Hruska, Kevin Dicrispino, Robert L. Brown, Thomas E. Cleveland
  • Patent number: 6703540
    Abstract: The present invention provides a method of making plants resistant to plant pathogens by transformation of host cells with a nucleic acid encoding a nonheme haloperoxidase. Transgenic plants which express a nonheme chloroperoxidase thereby resulting in enhanced resistance to phytopathogens are provided.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: March 9, 2004
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Thomas J. Jacks, Jeffrey W. Cary, Kanniah Rajasekaran, Thomas E. Cleveland, III, Karl-Heinz Van Pee
  • Patent number: 6183736
    Abstract: The invention relates to two lipopeptides a1 and a2 produced by Bacillus subtilis and their use as an anitfungal agent against Aspergillus flavus. Both peptides are cyclic, acidic and have broad range of antifungal and antimicrobial activity. Both peptides belong to the Bacillomycin D family. A method and composition for controlling aflatoxin contamination in plants susceptible to alflatoxin-producing fungi, like Aspergillus flavus or Aspergillus parasiticus is also disclosed.
    Type: Grant
    Filed: April 7, 1999
    Date of Patent: February 6, 2001
    Assignees: USDA/ARS Southern Regional Research Center, Auburn University
    Inventors: Anne-Laure Moyne, Thomas E. Cleveland, Sadik Tuzun